Close Menu

This article has been updated from a previous version to clarify information about Inscripta's early-access program and development plans for Onyx.

NEW YORK – Genome engineering company Inscripta said on Monday that it has closed a $150 million Series E financing round led by Fidelity Management & Research as well as funds and accounts advised by T. Rowe Price Associates.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.